Impact of Serum Apolipoprotein A-I on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer: a Propensity Score-Matched Analysis()

PURPOSE: We aimed to investigate the role of apolipoprotein A-I (ApoA-I) as a predictor of prognosis and treatment efficacy of bevacizumab in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy with or without bevacizumab. METHODS: We conducted a retrospective stud...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Quan, Qi, Huang, Yuanyuan, Chen, Qi, Qiu, Huijuan, Hu, Qiaozhen, Rong, Yuming, Li, Tingwei, Xia, Liangping, Zhang, Bei
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2017
Matèries:
Original article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5334545/
https://ncbi.nlm.nih.gov/pubmed/28292509
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2017.01.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars